000 | 01310 a2200313 4500 | ||
---|---|---|---|
005 | 20250517112054.0 | ||
264 | 0 | _c20180323 | |
008 | 201803s 0 0 eng d | ||
022 | _a2055-6845 | ||
024 | 7 |
_a10.1093/ehjcvp/pvw009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Leeuw, Anne E | |
245 | 0 | 0 |
_aSodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effects. _h[electronic resource] |
260 |
_bEuropean heart journal. Cardiovascular pharmacotherapy _c10 2016 |
||
300 |
_a244-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 | _aSodium-Glucose Transporter 2 |
650 | 0 | 4 | _aSodium-Glucose Transporter 2 Inhibitors |
700 | 1 | _ade Boer, Rudolf A | |
773 | 0 |
_tEuropean heart journal. Cardiovascular pharmacotherapy _gvol. 2 _gno. 4 _gp. 244-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/ehjcvp/pvw009 _zAvailable from publisher's website |
999 |
_c26336409 _d26336409 |